| License: Creative Commons: Attribution 3.0 PDF - Published Version (655kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-287880
- DOI to cite this document:
- 10.5283/epub.28788
Abstract
Background: Implantation of implantable cardioverter-defibrillators (ICD) from the left pectoral region is the standard therapeutical method. Increasing numbers of system revisions due to lead dysfunction and infections will consecutively increase the numbers of right-sided implantations. The reliability of devices implanted on the right pectoral side remains controversially discussed, and the ...

Owner only: item control page